Support for Institutional Clients
SYSTEM STATUS
FINRA BrokerCheck reports for Interactive Brokers and its investment professionals are available at www.finra.org/brokercheck
IBKR ProServe: Institutional Client Services
| Location | Number | Menu Options |
|---|---|---|
| Australia | +61 2 7259 9400 Direct dial +61 2 8550 5912 Direct dial |
1 Closing Order Desk 1/1 Place an Order to Close a Position 2 Login Assistance 2/1 Advisor & Advisor Client Login Help 2/2 Login Help for All Other Account Types 2/3 Security Device Assistance 3 Financial Advisors & Advisor Clients 4 Institutional, Hedge Fund, Prime Brokerage & Registered Broker Accounts 5 Technical Issues |
| Brazil | +1 475-267-0070 Direct dial 0800 762 0137 Toll-Free1 |
|
| Canada | (855) 700-2977 Toll-Free2 | |
| China | +86 21 6086 8590 Direct dial | |
| Hong Kong | +852 3107 8868 Direct dial +852 3002 0838 Direct dial |
|
| Hungary | 06 80 088 400 Toll-Free1 +36 1 701 0350 Direct Dial |
|
| Ireland | +353 1 264 0646 Direct dial +353 1 223 2358 Direct dial |
|
| Japan | +81 3-4578-0083 Direct dial | |
| Latin America (Spanish) | +1 561-803-4571 Direct dial | |
| Qatar | 800101360 Toll-Free1 | |
| Russia | 8 (800) 100-85-54 Toll-Free1 +41 41 562 09 34 Direct dial |
|
| Saudi Arabia | 800 850 0461 Toll-Free1 | |
| Singapore | +65 6990 5690 Direct dial +65 3117 7858 Direct dial |
|
| Switzerland | +41 41 562 09 30 Direct dial +41 41 563 78 00 Direct dial |
|
| United Arab Emirates | 800 03110144 Toll-Free1 | |
| United Kingdom | +44 20 3744 7300 Direct dial +44 20 3994 8826 Direct dial |
|
| United States | (866) 694-2757 Toll-Free2 +1 203-618-7791 Direct dial +1 475-200-0585 Direct dial |
Notes:
- Phone number is for local use only.
- Calls originating outside of a toll-free number's region will incur international charges.
Sales Contacts
IBKR has sales offices worldwide ready to support your trading needs. Choose your region to speak with a sales representative.
Video Tutorials
Information & Tools
Investor Grievance Escalation Matrix for IB India Accounts
- Please use the below channels of communication only for queries related to NSE Trading/NSDL Depository accounts held with IBKR India. Any other query will not attract a response.
- Please do not use the escalation email matrix as a first line of communication. Escalation emails sent without the details of a previous case history, such as a ticket number, chat, or call summary, will not be processed further.
Please contact our Client Services Team first using the standard modes of communication (chats, calls or tickets through your secure Client Portal for any assistance, If you do not receive a timely response or are not satisfied with the response provided, you can send an email with your case details (ticket number, chat/call summary), as per the escalation matrix below.
| Details of | Contact Person | Address | Contact Number | Email Address |
|---|---|---|---|---|
| Customer Care | Rinku Chauhan | 401-404, 4th Floor, Waterstones, Off International Airport Road, Andheri (E), Mumbai 400059 Maharashtra, India | +91-22-61289888 (Mon-Fri ; 10 am to 5 pm) |
customercareescalation.in@interactivebrokers.com |
| Head of Customer Care/Board Member | Praveen Kamath | +91-22-45917488 (Mon-Fri ; 10 am to 5 pm) |
customercareheadescalation.in@interactivebrokers.com | |
| Compliance Officer | Bina Shah | +91-22-61289825 (Mon-Fri ; 10 am to 5 pm) |
complianceofficerescalation.in@interactivebrokers.com |
Should you require additional support after contacting Client Services, you may submit a complaint or dispute to the following:
- Exchange: https://investorhelpline.nseindia.com/NICEPLUS/
- NSDL: https://www.epass.nsdl.com/complaints/websitecomplaints.aspx
- SEBI: https://scores.sebi.gov.in
Additionally, you can raise a complaint or dispute via the Online Dispute Resolution (ODR) portal http://smartodr.in. Please include your Service Ticket/Complaint Ref No. while raising your complaint at Exchange/Depository/SEBI SCORES/ODR Portal.
The NSE cautions and advises investors not to subscribe to any prohibited scheme or products. Participation in such prohibited schemes is at the investors' own risk, as such schemes are neither approved nor endorsed by the Exchange. Further details on the NSE Press releases can be found on their website here.